Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MTRAC Reviews - June 2014

MTRAC issued a new Commissioning Support review in June 2014. The review covers avanafil.

The avanafil (Spedra®) summary advises that this drug is suitable for restricted prescribing in primary care within the existing regulations imposed by the Department of Health for prescribing treatments for erectile dysfunction. The review notes that this medicine has relatively weak evidence because the currently published trials compared this agent to placebo rather and against an active PDE-5 inhibitor comparator such as sildenafil.

Action: Clinicians should be aware of these reviews and use the recommendations to guide appropriate use of these medicines in current practice.

Share 'MTRAC Reviews - June 2014' on Email Share 'MTRAC Reviews - June 2014' on Delicious Share 'MTRAC Reviews - June 2014' on Digg Share 'MTRAC Reviews - June 2014' on Facebook Share 'MTRAC Reviews - June 2014' on Google+ Share 'MTRAC Reviews - June 2014' on reddit Share 'MTRAC Reviews - June 2014' on StumbleUpon Share 'MTRAC Reviews - June 2014' on Twitter

atomic-wealth

One Comments to “MTRAC Reviews - June 2014”

  1. […] Commissioning Guidance (PDF) is an update to the review published in […]

    Pingback by MTRAC Reviews – August 2014 | Prescribing Advice for GPs — September 1, 2014 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,217 spam comments.

atomic-wealth
fond-illness
summer